Isotopia Global

Isotopia Molecular Imaging, often branded as Isotopia Global, is a premier radiopharmaceutical company specializing in the development, production, and distribution of diagnostic and therapeutic radioactive isotopes. The company is a leading global supplier of high-purity, no-carrier-added (n.c.a.) Lutetium-177, a critical component for targeted radionuclide therapies in oncology. Beyond isotope production, Isotopia develops "cold kits" for the rapid radiolabeling of imaging agents targeting prostate-specific membrane antigen (PSMA) and somatostatin receptors. Their vertically integrated model includes state-of-the-art GMP manufacturing facilities and a robust global supply chain to support the growing field of theranostics. Isotopia also operates as a CDMO, partnering with biotechnology firms to accelerate the clinical development of next-generation radiopharmaceuticals.